Shockwave Medical Inc Down 13.15% To $186.65 After Earnings Beat

Shockwave Medical Inc (SWAV) said after close Monday that it earned $0.92 per share in quarter three 2023.

On the revenue line, the company reported $186 million, beating estimates by $1.3 million.

In the same quarter a year ago, the company earned $0.92 per share on revenue of $131.3 million.

The stock is down 13.15% to $186.65 after the report.



Wall Street Analysts had an average rating of Buy on the stock prior to the report.

Trading in the five days leading up to the report earned Shockwave Medical Inc a Bullish Sentiment Rank from InvestorsObserver.

Shockwave Medical Inc has performed a little below average during the past few months. Before the report, Shockwave Medical Inc received a Long-Term Technical Rank by InvestorsObserver of 38, putting it in the bottom half of stocks. The firm set a 52-week high on June 14, 2023 at $315.95 and set a 52-week low on January 20, 2023 at $172.5.

ShockWave Medical Inc is a medical device company focused on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. Its intravascular lithotripsy technology is used in the treatment of calcified plaque. Geographically, the company generates its revenue from the United States, Europe and other countries.